lol @ the normalized earnings after the Vioxx write down, that is just pathetic IMO. There won't be a Vioxx case every year that they'll profit from in normal circumstances.
ROE declining, sits at about 10% now. I wonder what their ROC is with all the debt they have? It's probably lucky to be above their cost of capital, it's too close for comfort IMO.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$52.52 |
Change
-1.550(2.87%) |
Mkt cap ! $21.37B | |||
| Open | High | Low | Value | Volume |
| $51.37 | $53.58 | $51.11 | $35.93M | 685.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 95 | $52.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $52.69 | 433 | 2 |
View Market Depth
| Last trade - 16.10pm 01/07/2025 (20 minute delay) ? |
| SGH (ASX) Chart |